TAS2R13

gene
On this page

Also known as T2R13TRB3

Summary

TAS2R13 (taste 2 receptor member 13, HGNC:14919) is a protein-coding gene on chromosome 12p13, encoding Taste receptor type 2 member 13 (Q9NYV9). Receptor that may play a role in the perception of bitterness and is gustducin-linked.

This gene product belongs to the family of candidate taste receptors that are members of the G-protein-coupled receptor superfamily. These proteins are specifically expressed in the taste receptor cells of the tongue and palate epithelia. They are organized in the genome in clusters and are genetically linked to loci that influence bitter perception in mice and humans. In functional expression studies, they respond to bitter tastants. This gene maps to the taste receptor gene cluster on chromosome 12p13.

Source: NCBI Gene 50838 — RefSeq curated summary.

At a glance

  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_023920

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14919
Approved symbolTAS2R13
Nametaste 2 receptor member 13
Location12p13
Locus typegene with protein product
StatusApproved
AliasesT2R13, TRB3
Ensembl geneENSG00000212128
Ensembl biotypeprotein_coding
OMIM604792
Entrez50838

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000390677

RefSeq mRNA: 1 — MANE Select: NM_023920 NM_023920

CCDS: CCDS8635

Canonical transcript exons

ENST00000390677 — 1 exons

ExonStartEnd
ENSE000015085951090792610909562

Expression profiles

Bgee: expression breadth broad, 27 present calls, max score 94.40.

Top tissues by expression

92 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047394.40gold quality
corpus callosumUBERON:000233673.92gold quality
adrenal tissueUBERON:001830366.62gold quality
calcaneal tendonUBERON:000370164.03gold quality
bone marrow cellCL:000209262.10silver quality
colonic epitheliumUBERON:000039757.40gold quality
sural nerveUBERON:001548848.78silver quality
tonsilUBERON:000237247.54silver quality
skeletal muscle tissueUBERON:000113445.59silver quality
ventricular zoneUBERON:000305344.16silver quality
granulocyteCL:000009441.68silver quality
muscle tissueUBERON:000238541.20silver quality
urinary bladderUBERON:000125540.90silver quality
liverUBERON:000210740.85silver quality
hindlimb stylopod muscleUBERON:000425239.25gold quality
adrenal glandUBERON:000236938.06gold quality
primary visual cortexUBERON:000243637.49gold quality
ganglionic eminenceUBERON:000402337.40gold quality
kidneyUBERON:000211336.95gold quality
endometriumUBERON:000129536.69gold quality
cortical plateUBERON:000534336.47gold quality
apex of heartUBERON:000209835.94gold quality
stomachUBERON:000094534.78gold quality
mucosa of stomachUBERON:000119934.74gold quality
leukocyteCL:000073834.51gold quality
monocyteCL:000057634.39gold quality
right hemisphere of cerebellumUBERON:001489034.27gold quality
heartUBERON:000094834.14gold quality
cerebellar hemisphereUBERON:000224533.94gold quality
cerebellumUBERON:000203733.92gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): DDIT3

miRNA regulators (miRDB)

19 targeting TAS2R13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3120-5P100.0065.56965
HSA-MIR-3163100.0077.238605
HSA-MIR-60799.9773.625593
HSA-MIR-95-5P99.8972.173973
HSA-MIR-430799.8270.453374
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-135A-5P99.3671.851601
HSA-MIR-135B-5P99.3671.631613
HSA-MIR-4999-5P99.3569.15926
HSA-MIR-20B-3P99.2967.05784
HSA-MIR-4727-5P99.2367.551154
HSA-MIR-125399.1267.081688
HSA-MIR-670-3P99.0368.882404
HSA-MIR-26B-3P98.7167.491102
HSA-MIR-6731-3P98.6167.86749
HSA-MIR-366898.5268.76951
HSA-MIR-431798.4967.09987
HSA-MIR-397696.6767.791187
HSA-MIR-376A-2-5P96.4368.06715

Literature-anchored findings (GeneRIF, showing 3)

  • It found a single nucleotide polymorphism (SNP) located within the TAS2R13 gene, which showed a significant association with measures of alcohol consumption assessed via the Alcohol Use Disorders Identification Test (AUDIT). (PMID:22824251)
  • Genetic variation in TRPV1 and TAS2Rs influence sensations from sampled EtOH and may potentially influence how individuals initially respond to alcoholic beverages. (PMID:25257701)
  • Can cornelian cherry mask bitter taste of probiotic chocolate? Human TAS2R receptors and a sensory study with comprehensive characterisation of new functional product. (PMID:33556063)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusTas2r102ENSMUSG00000056901
mus_musculusTas2r124ENSMUSG00000060412
mus_musculusTas2r121ENSMUSG00000071150
rattus_norvegicusTas2r124ENSRNOG00000021430
rattus_norvegicusTas2r102ENSRNOG00000030993

Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)

Protein

Protein identifiers

Taste receptor type 2 member 13Q9NYV9 (reviewed: Q9NYV9)

Alternative names: Taste receptor family B member 3

All UniProt accessions (1): Q9NYV9

UniProt curated annotations — full annotation on UniProt →

Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.

Subcellular location. Membrane.

Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and palate epithelium and exclusively in gustducin-positive cells.

Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.

Similarity. Belongs to the G-protein coupled receptor T2R family.

RefSeq proteins (1): NP_076409* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007960TAS2RFamily

Pfam: PF05296

UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NYV9-F187.960.60

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 162, 166

Function

Pathways and Gene Ontology

Reactome pathways

9 pathways

IDPathway
R-HSA-418594G alpha (i) signalling events
R-HSA-420499Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-9717207Sensory perception of sweet, bitter, and umami (glutamate) taste
R-HSA-162582Signal Transduction
R-HSA-372790Signaling by GPCR
R-HSA-388396GPCR downstream signalling
R-HSA-500792GPCR ligand binding
R-HSA-9709957Sensory Perception
R-HSA-9717189Sensory perception of taste

MSigDB gene sets: 61 (showing top): GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_REGULATION_OF_CYTOKINESIS, GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS, GOBP_REGULATION_OF_CELL_DIVISION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, OCT1_B, GOBP_REGULATION_OF_CELL_CYCLE_PROCESS, GOBP_CELL_DIVISION

GO Biological Process (5): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), positive regulation of cytokinesis (GO:0032467), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)

GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), taste receptor activity (GO:0008527), bitter taste receptor activity (GO:0033038)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-6 pathways:

CategoryPathways
Signaling by GPCR2
GPCR downstream signalling1
GPCR ligand binding1
Sensory perception of taste1
Signal Transduction1
Sensory Perception1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
detection of chemical stimulus involved in sensory perception of taste2
transmembrane signaling receptor activity2
sensory perception of bitter taste1
cytokinesis1
regulation of cytokinesis1
positive regulation of cell division1
positive regulation of cell cycle process1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
sensory perception of chemical stimulus1
G protein-coupled receptor signaling pathway1
detection of chemical stimulus involved in sensory perception of bitter taste1
taste receptor activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

340 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TAS2R13GNAT3A8MTJ3842
TAS2R13OR52L1Q8NGH7622
TAS2R13OR11H1Q8NG94580
TAS2R13OR4F4Q96R69577
TAS2R13OR1E1P30953541
TAS2R13OR2L13Q8N349541
TAS2R13OR2T33Q8NG76528
TAS2R13OR10G8Q8NGN5520
TAS2R13OR2T1O43869513
TAS2R13OR2D2Q9H210506
TAS2R13OR52H1Q8NGJ2506
TAS2R13OR2A4O95047476
TAS2R13TAS1R2Q8TE23469
TAS2R13OR2J3O76001447
TAS2R13VN1R4Q7Z5H5417

IntAct

0 interactions, top by confidence:

BioGRID (2): CDC20 (Affinity Capture-Western), FZR1 (Affinity Capture-Western)

ESM2 similar proteins: P59528, P59530, Q5Y4Z2, Q645T9, Q645U9, Q645V1, Q645Y5, Q645Z3, Q645Z5, Q646A7, Q646B6, Q646B8, Q646C6, Q646D2, Q646D8, Q646D9, Q646F7, Q646G3, Q646G5, Q675B7, Q675B8, Q675B9, Q675C0, Q67ER8, Q67ES1, Q67ES5, Q67ES6, Q67ES9, Q67ET3, Q67ET5, Q7M707, Q7M711, Q7M712, Q7M713, Q7M715, Q7M717, Q7M718, Q7M720, Q7M725, Q7RTR8

Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

158 predictions. Top by Δscore:

VariantEffectΔscore
12:10908595:A:ACdonor_gain0.9900
12:10909368:T:TAdonor_gain0.9900
12:10908442:G:Cdonor_gain0.9500
12:10909365:ACAT:Adonor_gain0.9500
12:10909366:CATC:Cdonor_gain0.9500
12:10908437:A:Cdonor_gain0.9400
12:10909362:T:Cdonor_gain0.9200
12:10908681:C:CCacceptor_gain0.9100
12:10908681:CTG:Cacceptor_loss0.9000
12:10908682:T:Cacceptor_loss0.9000
12:10909395:T:TAdonor_gain0.9000
12:10908676:TGTTT:Tacceptor_gain0.8400
12:10908679:TT:Tacceptor_gain0.8400
12:10909294:T:Adonor_gain0.8400
12:10908617:TATGG:Tdonor_gain0.8000
12:10908618:ATGGA:Adonor_gain0.8000
12:10908621:G:Tdonor_gain0.8000
12:10908619:T:Cdonor_gain0.7900
12:10908678:TTT:Tacceptor_gain0.7900
12:10909350:T:Cdonor_gain0.7800
12:10909369:C:Adonor_gain0.7800
12:10909367:A:Cdonor_gain0.7600
12:10909367:AT:Adonor_gain0.7500
12:10908795:A:ACdonor_gain0.7300
12:10908796:C:CCdonor_gain0.7300
12:10908683:G:Cacceptor_loss0.7100
12:10908677:GTTT:Gacceptor_gain0.6500
12:10909108:A:ACdonor_gain0.6400
12:10909109:C:CCdonor_gain0.6400
12:10908441:AG:Adonor_gain0.6200

AlphaMissense

2006 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:10908942:A:CF119L0.902
12:10908942:A:TF119L0.902
12:10908944:A:GF119L0.902
12:10908741:G:CF186L0.870
12:10908741:G:TF186L0.870
12:10908743:A:GF186L0.870
12:10908987:G:CS104R0.847
12:10908987:G:TS104R0.847
12:10908989:T:GS104R0.847
12:10909221:A:CF26L0.832
12:10909221:A:TF26L0.832
12:10909223:A:GF26L0.832
12:10908957:G:CF114L0.828
12:10908957:G:TF114L0.828
12:10908959:A:GF114L0.828
12:10908588:G:CF237L0.807
12:10908588:G:TF237L0.807
12:10908590:A:GF237L0.807
12:10908570:A:CS243R0.786
12:10908570:A:TS243R0.786
12:10908572:T:GS243R0.786
12:10908738:A:CS187R0.783
12:10908738:A:TS187R0.783
12:10908740:T:GS187R0.783
12:10909121:A:GW60R0.776
12:10909121:A:TW60R0.776
12:10908726:A:CF191L0.768
12:10908726:A:TF191L0.768
12:10908728:A:GF191L0.768
12:10909248:G:CF17L0.760

dbSNP variants (sampled 300 via entrez): RS1001141532 (12:10908525 C>G), RS1001724816 (12:10911492 T>C), RS1001745876 (12:10911484 G>C), RS1002116116 (12:10907453 C>T), RS1003464289 (12:10910408 G>A,T), RS1003624566 (12:10910373 G>A), RS1003821563 (12:10910640 G>C), RS1004038128 (12:10907804 A>G), RS1004292612 (12:10910850 T>C,G), RS1005737601 (12:10909522 T>C), RS1007206506 (12:10911078 G>C,T), RS1007268362 (12:10910881 T>G), RS1007878217 (12:10908353 T>A,C), RS1007886475 (12:10910925 T>G), RS1007929043 (12:10907912 A>G)

Disease associations

OMIM: gene MIM:604792 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523471 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL434ISOPROTERENOL440,234

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Taste 2 receptors

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.31EC504.9nMISOPROTERENOL

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
fluorene-9-bisphenolincreases expression1
CGP 52608affects binding, increases reaction1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Asbestos, Crocidoliteaffects expression1
Particulate Matterincreases abundance, increases expression1

ChEMBL screening assays

7 unique, capped per target: 7 functional

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4346429FunctionalAntagonist activity at recombinant human TAS2R13 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of oxyphenonium-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dDiscovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.